Last week 7 publications:
- Practical cost efficiency of multi -genetic panel sequencing to inform the decision of treatment for high -quality non -small cell lung cancer: Population -based study | link
- Full genome sequencing evaluation of rare diseases in neonatal screening: Evidence synthesis in a series of systematic review | link
- To inform the therapeutic crystal of metastatic colon cancer, using genomic heterogeneity: Apply the value of heterogeneous framework | link
- Analysis of exploration costs of 37-genetic panels to guide the treatment for patients with intermediate risk bone marrow malignant tumors | link
- Implementation of the National Prenatal Execution Excomsing Service in the UK: Expity Efficiency Analysis | link
- Oncology next -generation sequencing: Economic Evaluation Challenge | link
- Cost Utility Analysis of Multi -Genetic Analysis to Guide Treatment Decisions for Node Early Breast Cancer | link
I am happy to share other publications that I missed this week. I post this update every week on Tuesdays, but only when I see a related publication. Suppose that if the update is not seen on Tuesday, it has become a quiet state of health economy and genome publications.
